Skip to main content

Table 1 Demographic and general sample description

From: Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study

Reported cases Male (%) Female (%)
 Gender (M/F) 25 (81) 6 (19)
Variables Male (median (IQR)) Female (median (IQR))
 Age (year) 62 (57–67) 71 (62–74)
 BMI (kg/m2) 27.8 (25.3–31.1) 29.4 (29.3–30.8)
 Symptoms-to-ICU (days) 9 (8–12) 7 (7–7)
 In-hospital pre-ICU LOS (days) 2 (1–5) 2.5 (2–3)
 ICU LOS 14 (9–19) 12.5 (11.2–16.7)
 PFmed 195 (159.5–220) 165.5 (136.1–183.3)
 PLR 436 (218–623) 305 (180–565)
 CT scan (L:H) 6:15 2:2
 Intubated patients (%) 22 of 25 (88) 6 of 6 (100)
 Tracheostomy (%) 21 of 25 (84) 4 of 6 (67)
 VAPs (%) 13 of 25 (52) 2 of 6 (33)
 Pro-coagulative disorders (%) 3 of 25 (12) 0 of 6 (0)
 Pnx (%) 7 of 25 (28) 1 of 6 (17)
 CRRT (%) 10 of 25 (40) 1 of 6 (17)
 Admitted from other centres (%) 12 of 25 (48) 3 of 6 (50)
 Mortality (%) 7 of 21 (33)
4 men still admitted in our ICU
1 of 6 (17)
  1. BMI body mass index, CRRT continuous renal-replacement therapy, CT scan computed tomography (only those with both images and radiologic report available—H stays for high-elastance pattern and L stays for low-elastance pattern), ICU intensive care unit, IQR interquartile range, LOS length of stay, Mortality 21 men over 25 enrolled because 4 are still in our ICU, PFmed means PaO2/FiO2 ratio during the first 24 h of ICU stay, PLR platelet-to-lymphocyte ratio on the day of ICU admission, Pnx pneumothorax, Pro-coagulative disorders deep-vein thrombosis, ischaemic stroke or massive pulmonary embolism, VAP ventilator-acquired pneumonia